“…Microorganisms are the more readily reproducible source of bioactive compounds in comparison to the plants and animals. According to the statics of the microbial-derived commercial drugs, actinomycetes, fungi, and myxobacteria are the richest bioresources of structurally unique and medically important compounds (Harvey, 2008;Reichenbach, Gerth, Irschik, Kunze, & Höfle, 1988;Fatemeh Salimi, Hamedi, Motevaseli, & Mohammadipanah, 2019;F Salimi, Jafari-Nodooshan, Zohourian, Kolivand, & Hamedi, 2018;Schaberle, Lohr, Schmitz, & Konig, 2014;Vasundhara, Reddy, & Kumar, 2019;Watve, Tickoo, Jog, & Bhole, 2001). Many compounds with anti-inflammatory activity have been extracted from microorganisms and an overview of these prodrugs is summarized in Tables 1 and 2.…”